Zobrazeno 1 - 10
of 77
pro vyhledávání: '"Hiroshi KOHARA"'
Publikováno v:
Journal of Plant Interactions, Vol 13, Iss 1, Pp 442-449 (2018)
Breeding of competitive cultivars has long been fraught with difficulty owing to limited knowledge of the genetic basis of competitive ability. In this study, we examined the diversity of competitive ability in Asian rice and the genetic basis of thi
Externí odkaz:
https://doaj.org/article/902a74ce40504adfb1fed797de88ab33
Autor:
Yuka Yoshinouchi, Yukiko Sorayama, Shiro Kitano, Michiya Matsusaki, Shinji Irie, Yasuyuki Naito, Hiroshi Kohara
Publikováno v:
Acta Biomaterialia. 140:275-288
In vitro Construction of the liver sinusoidal structure using artificial tissue is an important but worthwhile challenge, particularly for assessing the risk of diseases such as sinusoidal obstruction syndrome (SOS). Current models are unsuitable for
Autor:
Yuta Tanaka, Masaki Seto, Keiko Kakegawa, Kazuaki Takami, Fumiaki Kikuchi, Takeshi Yamamoto, Minoru Nakamura, Masaki Daini, Masataka Murakami, Tomohiro Ohashi, Takahito Kasahara, Junsi Wang, Zenichi Ikeda, Yasufumi Wada, Florian Puenner, Takahiro Fujii, Masakazu Inazuka, Sho Sato, Tomohiko Suzaki, Jeong-Ho Oak, Yuichi Takai, Hiroshi Kohara, Kouya Kimoto, Hideyuki Oki, Satoshi Mikami, Minoru Sasaki
Publikováno v:
Journal of Medicinal Chemistry. 65:4270-4290
Inhibition of glucosylceramide synthase (GCS) is a major therapeutic strategy for Gaucher's disease and has been suggested as a potential target for treating Parkinson's disease. Herein, we report the discovery of novel brain-penetrant GCS inhibitors
Autor:
Kosuke Harada, Hideki Furukawa, Hiroshi Kohara, Koki Nishimura, Hisakazu Komori, Yoshiko Okai, Yuta Arai, Yuhei Yamamoto, Katsuhiko Yamamoto, Akio Imanishi, Tadahiro Shinozawa
Publikováno v:
Toxicology in Vitro. 89:105569
Autor:
Yoshiyuki Yamaguchi, Makoto Takeda, Ryo Kurita, Takafumi Hiramoto, Hiroyuki Sasaki, Kota Inoue, Akihide Ryo, Yasushi Soda, Shinji Okano, Kenji Ichiyanagi, Atsushi Muraguchi, Hiroshi Kohara, Shohei Miyamoto, Hidehiro Toh, Yasuki Hijikata, Hiroshi Hamana, Hiroyuki Kishi, Maino Tahara, Jiyuan Liao, Kenzaburo Tani, Yoshie Miura, Yoshinao Oda
Publikováno v:
Mol Ther
Recent advances in gene therapy technologies have enabled the treatment of congenital disorders and cancers and facilitated the development of innovative methods, including induced pluripotent stem cell (iPSC) production and genome editing. We recent
Publikováno v:
Toxicology in vitro : an international journal published in association with BIBRA. 74
Here, we established a high-throughput in vitro assay system to predict reactive metabolite (RM) formation. First, we performed the glutathione (GSH) consumption assay to monitor GSH levels as an index of RM formation potential using HepaRG cells pre
Autor:
Hiroshi Kohara, Shiro Kitano, Shinji Irie, Yasuyuki Naito, Yuka Yoshinouchi, Michiya Matsusaki, Yukiko Sorayama
Publikováno v:
SSRN Electronic Journal.
In vitro Construction of the liver sinusoidal structure using artificial tissue is an important but worthwhile challenge, particularly for assessing the risk of diseases such as sinusoidal obstruction syndrome (SOS). Current models are unsuitable for
Publikováno v:
Journal of Plant Interactions, Vol 13, Iss 1, Pp 442-449 (2018)
Breeding of competitive cultivars has long been fraught with difficulty owing to limited knowledge of the genetic basis of competitive ability. In this study, we examined the diversity of competitive ability in Asian rice and the genetic basis of thi
Autor:
Hiroyuki Inoue, Megumi Narusawa, Shohei Miyamoto, Chika Sakamoto, Yumiko Matsumura, Kenzaburo Tani, L Hirose-Yotsuya, Atsushi Takahashi, Hiroshi Kohara, Yoshie Ogawa, Kazunari Yamada
Publikováno v:
Cancer Gene Therapy. 24:165-174
Among cancer immunotherapies, granulocyte-macrophage colony-stimulating factor (GM-CSF) gene-transduced tumor cell vaccine (GVAX) therapies appear promising and have been shown to be safe and effective in multiple clinical trials. However, the antitu
Autor:
Kosuke Harada, Hiroshi Kohara, Yoshiko Okai, Matthew Wagoner, Akimitsu Miyawaki, Toshikatsu Matsui, Kazumasa Miyamoto, Kazunori Yamanaka, Piyush Bajaj, Tadahiro Shinozawa
Publikováno v:
Toxicological sciences : an official journal of the Society of Toxicology. 173(2)
Cholestasis resulting from hepatic bile acid efflux transporter inhibition may contribute to drug-induced liver injury (DILI). This condition is a common safety-related reason for drug attrition and withdrawal. To screen for safety risks associated w